Javascript must be enabled to continue!
Characterizing obesity-HFpEF in younger acute respiratory failure patients
View through CrossRef
AbstractBackgroundHypoxic hypercapnic respiratory failure is a major cause of acute hospitalization. Cardiopulmonary insults can lead to respiratory distress and, if untreated, respiratory failure. West Virginia has the highest prevalence of obesity in the nation, accounting for the higher incidence of heart failure with preserved ejection fraction (HFpEF). This diagnosis is elusive in younger patients below age 65 years because echocardiograms are often normal and invasive hemodynamics are not widely measured. H2FPEF score, “obesity age” (BMI + age), and newly described HFpEF-ABA scores may predict obesity-related HFpEF in acute respiratory failure settings. Given the global rise in obesity, early identification of HFpEF is critical to optimizing respiratory failure care.PurposeThis cohort study investigates the burden of obesity-related HFpEF in patients younger than 65 years old presenting with respiratory failure.MethodsThe study included patients ≤65 years of age admitted to Charleston Area Medical Center from 1/2023-12/2023 with respiratory failure, BMI > 30 kg/m2, and EF > 50%. Patients with specific cardiomyopathies or identifiable triggers for for respiratory failure were excluded. “Premature HFpEF” was defined as ‘obesity years’ >100. Demographic data on BMI, echocardiographic and hemodynamic findings were analyzed. Logistic regression was used to assess the relationship between premature HFpEF and respiratory failure, adjusting for confounders.ResultsAmong 44 patients with respiratory failure, 64% exhibited premature obesity-related heart failure with preserved ejection fraction (HFpEF), characterized by a mean age and body mass index (BMI) of 111.5 kg/m2-years. These patients demonstrated elevated left ventricular end-diastolic pressure (LVEDP) exceeding 18 mmHg during cardiac catheterization. H2FPEF score could not be measured due to obesity limiting Doppler echocardiographic studies. The HFpEF -ABA score was > 80% and ‘obesity age’ was > 95 in 85% of the cohort.ConclusionEarly recognition of obesity-related HFpEF enables healthcare providers to tailor individualized treatment regimens. Preventive strategies focused on obesity reduction can reverse associated comorbidities, improve patient outcomes, and lower healthcare costs in the long run.
Cold Spring Harbor Laboratory
Title: Characterizing obesity-HFpEF in younger acute respiratory failure patients
Description:
AbstractBackgroundHypoxic hypercapnic respiratory failure is a major cause of acute hospitalization.
Cardiopulmonary insults can lead to respiratory distress and, if untreated, respiratory failure.
West Virginia has the highest prevalence of obesity in the nation, accounting for the higher incidence of heart failure with preserved ejection fraction (HFpEF).
This diagnosis is elusive in younger patients below age 65 years because echocardiograms are often normal and invasive hemodynamics are not widely measured.
H2FPEF score, “obesity age” (BMI + age), and newly described HFpEF-ABA scores may predict obesity-related HFpEF in acute respiratory failure settings.
Given the global rise in obesity, early identification of HFpEF is critical to optimizing respiratory failure care.
PurposeThis cohort study investigates the burden of obesity-related HFpEF in patients younger than 65 years old presenting with respiratory failure.
MethodsThe study included patients ≤65 years of age admitted to Charleston Area Medical Center from 1/2023-12/2023 with respiratory failure, BMI > 30 kg/m2, and EF > 50%.
Patients with specific cardiomyopathies or identifiable triggers for for respiratory failure were excluded.
“Premature HFpEF” was defined as ‘obesity years’ >100.
Demographic data on BMI, echocardiographic and hemodynamic findings were analyzed.
Logistic regression was used to assess the relationship between premature HFpEF and respiratory failure, adjusting for confounders.
ResultsAmong 44 patients with respiratory failure, 64% exhibited premature obesity-related heart failure with preserved ejection fraction (HFpEF), characterized by a mean age and body mass index (BMI) of 111.
5 kg/m2-years.
These patients demonstrated elevated left ventricular end-diastolic pressure (LVEDP) exceeding 18 mmHg during cardiac catheterization.
H2FPEF score could not be measured due to obesity limiting Doppler echocardiographic studies.
The HFpEF -ABA score was > 80% and ‘obesity age’ was > 95 in 85% of the cohort.
ConclusionEarly recognition of obesity-related HFpEF enables healthcare providers to tailor individualized treatment regimens.
Preventive strategies focused on obesity reduction can reverse associated comorbidities, improve patient outcomes, and lower healthcare costs in the long run.
Related Results
Left Atrioventricular Coupling Index in Heart Failure Patients Using Echocardiography: A Simple Yet Effective Metric
Left Atrioventricular Coupling Index in Heart Failure Patients Using Echocardiography: A Simple Yet Effective Metric
AbstractBackgroundHeart failure (HF) is a global health challenge, with significant rates of hospitalization and mortality. Timely diagnosis is crucial for patient outcomes. Noninv...
Clinical outcomes of patients with heart failure and preserved ejection fraction in Chinese
Clinical outcomes of patients with heart failure and preserved ejection fraction in Chinese
Background
Although heart failure is recognised as a major health problem, little is known about heart failure with preserved ejection fraction (HFPEF) in the Chi...
Clinical and treatment perspectives for heart failure with preserved ejection fraction
Clinical and treatment perspectives for heart failure with preserved ejection fraction
[ACCESS RESTRICTED TO THE UNIVERSITY OF MISSOURI AT AUTHOR'S REQUEST.] Heart failure with preserved ejection fraction (HFpEF) currently represents half of the ~6 million heart fail...
Abstract 4144947: Invasive Hemodynamic Validation of a Novel Echocardiographic Artificial Intelligence Screening Tool for HFpEF
Abstract 4144947: Invasive Hemodynamic Validation of a Novel Echocardiographic Artificial Intelligence Screening Tool for HFpEF
Background:
Right heart catheterization (RHC) is the gold standard for diagnosing heart failure with preserved ejection fraction (HFpEF). An FDA-approved artificial int...
Epicardial fat volume assessment via cardiac computed tomography: a novel indicator in heart failure with preserved ejection fraction
Epicardial fat volume assessment via cardiac computed tomography: a novel indicator in heart failure with preserved ejection fraction
Abstract
Background
Heart failure with preserved ejection fraction (HFpEF) is a complex condition characterized by high morbidity and mortality, ...
Galectin-3 in Heart Failure with Preserved Ejection Fraction and Persistent Atrial Fibrillation Versus Sinus Rhythm. Correlation with Left Atrial Volume and N-Terminal Pro B-Type Natriuretic Peptide
Galectin-3 in Heart Failure with Preserved Ejection Fraction and Persistent Atrial Fibrillation Versus Sinus Rhythm. Correlation with Left Atrial Volume and N-Terminal Pro B-Type Natriuretic Peptide
Background: Galectin-3 (Gal-3) is considered both a profibrotic biomarker in Heart Failure with preserved Ejection Fraction (HFpEF) and a biomarker of atrial remodeling in Atrial F...
Catheter ablation as a potential treatment alternative for atrial fibrillation among patients with heart failure with preserved ejection fraction: a retrospective cohort study
Catheter ablation as a potential treatment alternative for atrial fibrillation among patients with heart failure with preserved ejection fraction: a retrospective cohort study
Abstract
Background
In patients with heart failure with reduced ejection fraction, catheter ablation for atrial fibrillation is a useful alternative to drug-induced rhythm...
Insulin Resistance/Hyperinsulinemia as an Independent Risk Factor for the Development and Worsening of HFpEF
Insulin Resistance/Hyperinsulinemia as an Independent Risk Factor for the Development and Worsening of HFpEF
Insulin resistance/hyperinsulinemia as an independent risk factor for the development and worsening of HFpEF.
Serafino Fazio MD¹, Valentina Mercurio MD, PhD2, Valeria Fazio MD3, An...

